These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26010880)

  • 1. The Stapled AKAP Disruptor Peptide STAD-2 Displays Antimalarial Activity through a PKA-Independent Mechanism.
    Flaherty BR; Wang Y; Trope EC; Ho TG; Muralidharan V; Kennedy EJ; Peterson DS
    PLoS One; 2015; 10(5):e0129239. PubMed ID: 26010880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2.
    Bendzunas NG; Dörfler S; Autenrieth K; Bertinetti D; Machal EMF; Kennedy EJ; Herberg FW
    Bioorg Med Chem; 2018 Mar; 26(6):1174-1178. PubMed ID: 29449124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKA-type I selective constrained peptide disruptors of AKAP complexes.
    Wang Y; Ho TG; Franz E; Hermann JS; Smith FD; Hehnly H; Esseltine JL; Hanold LE; Murph MM; Bertinetti D; Scott JD; Herberg FW; Kennedy EJ
    ACS Chem Biol; 2015 Jun; 10(6):1502-10. PubMed ID: 25765284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform-selective disruption of AKAP-localized PKA using hydrocarbon stapled peptides.
    Wang Y; Ho TG; Bertinetti D; Neddermann M; Franz E; Mo GC; Schendowich LP; Sukhu A; Spelts RC; Zhang J; Herberg FW; Kennedy EJ
    ACS Chem Biol; 2014 Mar; 9(3):635-42. PubMed ID: 24422448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an A-kinase anchoring protein-like suggests an alternative way of PKA anchoring in Plasmodium falciparum.
    Bandje K; Naissant B; Bigey P; Lohezic M; Vayssières M; Blaud M; Kermasson L; Lopez-Rubio JJ; Langsley G; Lavazec C; Deloron P; Merckx A
    Malar J; 2016 Apr; 15():248. PubMed ID: 27129434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Kinase A Is Essential for Invasion of Plasmodium falciparum into Human Erythrocytes.
    Wilde ML; Triglia T; Marapana D; Thompson JK; Kouzmitchev AA; Bullen HE; Gilson PR; Cowman AF; Tonkin CJ
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective disruption of the AKAP signaling complexes.
    Kennedy EJ; Scott JD
    Methods Mol Biol; 2015; 1294():137-50. PubMed ID: 25783883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining A-Kinase Anchoring Protein (AKAP) Specificity for the Protein Kinase A Subunit RI (PKA-RI).
    Autenrieth K; Bendzunas NG; Bertinetti D; Herberg FW; Kennedy EJ
    Chembiochem; 2016 Apr; 17(8):693-697. PubMed ID: 26611881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Inhibition of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 with a Constrained J Domain-Derived Disruptor Peptide.
    Flaherty BR; Ho TG; Schmidt SH; Herberg FW; Peterson DS; Kennedy EJ
    ACS Infect Dis; 2019 Apr; 5(4):506-514. PubMed ID: 30746930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function.
    Patel HH; Hamuro LL; Chun BJ; Kawaraguchi Y; Quick A; Rebolledo B; Pennypacker J; Thurston J; Rodriguez-Pinto N; Self C; Olson G; Insel PA; Giles WR; Taylor SS; Roth DM
    J Biol Chem; 2010 Sep; 285(36):27632-40. PubMed ID: 20581396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
    Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-permeable peptide-based disruption of endogenous PKA-AKAP complexes: a tool for studying the molecular roles of AKAP-mediated PKA subcellular anchoring.
    Faruque OM; Le-Nguyen D; Lajoix AD; Vives E; Petit P; Bataille D; Hani EH
    Am J Physiol Cell Physiol; 2009 Feb; 296(2):C306-16. PubMed ID: 19073898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Plasmodium with constrained peptides and peptidomimetics.
    Helton LG; Kennedy EJ
    IUBMB Life; 2020 Jun; 72(6):1103-1114. PubMed ID: 32037730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based bacteriophage screening for AKAP-selective PKA regulatory subunit variants.
    Walker-Gray R; Gold MG
    Methods Mol Biol; 2015; 1294():167-80. PubMed ID: 25783885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein kinase (PfPKA) as a therapeutic target.
    Haste NM; Talabani H; Doo A; Merckx A; Langsley G; Taylor SS
    Microbes Infect; 2012 Aug; 14(10):838-50. PubMed ID: 22626931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for small molecule disruptors of AKAP-PKA interactions.
    Schächterle C; Christian F; Fernandes JM; Klussmann E
    Methods Mol Biol; 2015; 1294():151-66. PubMed ID: 25783884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes.
    Syin C; Parzy D; Traincard F; Boccaccio I; Joshi MB; Lin DT; Yang XM; Assemat K; Doerig C; Langsley G
    Eur J Biochem; 2001 Sep; 268(18):4842-9. PubMed ID: 11559352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
    Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
    J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.